drugset / Trial / NCT04161001
Clinical Trail to Evaluate the Efficacy and Safety of DWJ1451
RandomizedParallel-groupDouble-blindTreatment
Summary
* the change of sitSBP based on baseline between Treatment arm and control 1 arm \[ Time Frame: 8 weeks \] * the change of LDL-C based on baseline between Treatment arm and control2 arm \[ Time Frame: 8 weeks \]
Timeline
- Start
- 2019-11-20
- Primary completion
- 2021-11-20
- Completion
- 2022-02-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amlodipine | Other / unclassified | 10 mg | — |
| Subject | Ezetimibe | Unknown | 10 mg | — |
| Subject | Rosuvastatin | Small molecule | 20 mg | — |
| Comparator | Olmesartan | Other / unclassified | 40 mg | — |
Indications
No indication recorded.